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This population-based study investigates genotype–phenotype correlations of “low-
normal” CGG repeats in the fragile X mental retardation 1 (FMR1) gene. FMR1 plays an
important role in brain development and function, and encodes FMRP (fragile X mental
retardation protein), an RNA-binding protein that regulates protein synthesis impacting
activity-dependent synaptic development and plasticity. Most past research has focused
on CGG premutation expansions (41–200 CGG repeats) and on fragile X syndrome (200+
CGG repeats), with considerably less attention on the other end of the spectrum of CGG
repeats. Using existing data, older adults with 23 or fewer CGG repeats (2 SDs below
the mean) were compared with age-peers who have normal numbers of CGGs (24–40)
with respect to cognition, mental health, cancer, and having children with disabilities.
Men (n = 341 with an allele in the low-normal range) and women (n = 46 with two
low-normal alleles) had signiﬁcantly more difﬁculty with their memory and ability to solve
day to day problems. Women with both FMR1 alleles in the low-normal category had
signiﬁcantly elevated odds of feeling that they need to drink more to get the same effect
as in the past. These women also had two and one-half times the odds of having had
breast cancer and four times the odds of uterine cancer. Men and women with low-normal
CGGs had higher odds of having a child with a disability, either a developmental disability
or a mental health condition. These ﬁndings are in line with the hypothesis that there
is a need for tight neuronal homeostatic control mechanisms for optimal cognitive and
behavioral functioning, and more generally that low numbers as well as high numbers of
CGG repeats may be problematic for health.
Keywords: FMR1 CGG expansions, fragile X syndrome, genotype–phenotype correlations
INTRODUCTION
The fragile X mental retardation 1 (FMR1) gene plays an impor-
tant role in brain development and function (Brown, 2002). This
gene encodes FMRP (fragile X mental retardation protein), an
RNA-binding protein that regulates protein synthesis impacting
activity-dependent synaptic development and plasticity (Bassell
and Warren, 2008).
The full mutation of the gene, a trinucleotide (CGG) repeat
expansion, results in fragile X syndrome, which occurs when
there are more than 200 CGG repeats in the 5′ untranslated
region of the FMR1 gene, resulting in the gene becoming fully
methylated and thus silenced. The premutation and gray zone are
deﬁned, respectively, as 55–200 CGG repeats, and 45–54 CGG
repeats, according to the American College of Medical Genetics
(Maddalena et al., 2001). Some recent studies have used a lower
boundary to deﬁne the beginning of the gray zone (e.g., 41 CGG
repeats in Hall et al., 2011). There has been intense interest in
FMR1 CGG expansions from the perspectives of basic science,
genotype–phenotype correlations, epidemiology, and public pol-
icy. However, very little attentionhas been focusedon theother end
of the spectrum, namely smaller than normal numbers of CGG
repeats. The purpose of the present paper is to present descrip-
tive data on genotype–phenotype correlations on what has been
termed“low-normal”numbers of CGG repeats (Chen et al., 2003).
Studies of FMR1 CGG repeats have reported a wide normal
range, with the modal number of repeats being 30 (Fu et al., 1991;
Chen et al., 2003). While epidemiological studies have estimated
the prevalence of CGG expansions (Seltzer et al., 2012; Tassone
et al., 2012; Maenner et al., 2013), low numbers of CGG repeats
have been reported in only several studies and no epidemiological
studies have yet been conducted. For example, Fu et al. (1991)
reported that six CGG repeats was the lowest in the collection of
samples they analyzed. Kremer et al. (1991) concluded that the
normal gene has 40 ± 25 CGG repeats, and by this standard as
few as 15 CGG repeats would be considered to be in the normal
range. Snow et al. (1993) characterized the CGG repeat at the
FMR1 locus in more than 700 individuals, with the lowest repeat
length reported to be 13 CGGs. Wang et al. (2013) studied healthy
adult males, with the lowest number of CGG repeats found to
be 19.
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Chen et al. (2003) reported that the efﬁciency of translation
was a function of the number of CGG repeats, with the modal
number of 30 repeats conferring the greatest efﬁciency of trans-
lation. Their data showed that having fewer or greater numbers
of CGG repeats reduced the efﬁciency of the translation. With
respect to the low end of the distribution, they observed that
the efﬁciency of translation increased by nearly twofold as the
numbers of CGG repeats increased from 0 to 30. This observa-
tion suggests a possible clinical phenotype associated with low
numbers of CGG repeats, and also that there may be some simi-
larities between the clinical manifestations of both low numbers
of CGG repeats and expansions, because both are associated with
inefﬁcient translation.
A clinical report of two cases with duplications of the FMR1
gene and two cases with deletion of FMR1 showed that “both loss
and gain of FMR1 copy number can lead to overlapping neurode-
velopmental phenotypes”(Nagamani et al., 2012, p. 333). Ramocki
and Zoghbi (2008) articulated the necessity of tight neuronal
homeostatic controlmechanisms for normal cognition and behav-
ior, and suggested that neurodevelopmental and neuropsychiatric
disorders may in part be the result of imbalances in homeostatic
controls in multiple genes, including FMR1.
Two other studies offer clues about possible effects of low-
normal numbers of CGG repeats in the FMR1 gene. Wang et al.
(2013) reported the inﬂuence of FMR1 on working memory and
brain structure in normal males. Although CGG repeat length was
not directly associated with working memory or brain structure in
this sample, FMR1 mRNA and FMRP were signiﬁcant correlates.
The study ﬁndings suggest that lower levels of gene expression,
even within the normal CGG repeat range, have negative effects
on cognition.
Low CGG repeats in the FMR1 gene have also been implicated
in research on reproductive biology. Weghofer et al. (2012) cross-
tabulated the co-occurrence of BRCA1/2 mutations and FMR1
repeat length distribution, and observed that BRCA1/2 carri-
ers almost invariably had low numbers of CGG repeats in their
FMR1 gene (<26 CGGs), compared to controls. They inferred
that BRCA1/2 mutations are embryo-lethal unless rescued by
low CGG repeats in the FMR1 gene, and predicted that women
with low FMR1 CGG repeats should have an increased risk of
BRCA1/2-associated cancers.
The present study is a secondary analysis of an existing
population-based, non-clinical sample that integrates phenotypic
informationwith genetic data including FMR1CGGrepeat length.
We identiﬁed 341 men who fell into the low-normal category of
CGG repeats (see below for the deﬁnition of low-normal). We
also identiﬁed 46 women for whom both alleles were in the low-
normal category. We examined speciﬁc characteristics of these
individuals with low numbers of CGG repeats in the FMR1 gene
and whether they differed from those who have normal num-
bers of CGG repeats. We carefully selected the study variables to
reﬂect domains implicated in past research to be correlated with
low numbers of CGG repeats, namely cognition (Ramocki and
Zoghbi, 2008; Wang et al., 2013), mental health (Ramocki and
Zoghbi, 2008), and cancers of the breast and uterus (Weghofer
et al., 2012). Since the numbers of CGG repeats in the FMR1
gene are passed from parent to child, we also examined whether
low numbers of CGG repeats would be associated with elevated
odds of having children with neurocognitive or neuropsychiatric
disabilities, as these data were also available.
MATERIALS AND METHODS
WISCONSIN LONGITUDINAL STUDY
Data were obtained from the Wisconsin Longitudinal Study
(WLS), a random sample of 10,317 women and men who gradu-
ated from Wisconsin high schools in 1957, representing one-third
of that age cohort (Hauser et al., 1998). In 1957, 75% of Wisconsin
18 year olds were high school graduates. Follow-up studies were
conducted in 1975 with 9,138 (90.1%) surviving members of the
original sample when they were, on average, 36 years old; in 1992
with 8,493 (87.2%) of the surviving respondents when they were
in their early 50 s; and in 2004 with 7,265 (80.0%) of the surviv-
ing respondents when they were in their mid-60 s; and in 2011
with 5,969 (68.4%) of the surviving respondents when they were
71 years of age. In addition, parallel data collection procedures
were conducted with one randomly selected sibling of a subset of
the respondents in 1977, 1994, 2005, and 2011, with 5,823 siblings
participating in one or more of these data collection points. The
original respondents weremembers of a single cohort (high school
graduates in the year 1957), but their siblings ranged from age 46
to 92 when the data reported here were collected (62.4% of the
entire sample was age 71 or 72 at that time).
Although all of the original WLS participants were high school
graduates, as were 93% of their siblings, WLS participants ranged
in IQ score (as measured during high school) from a low of 61
(the ﬂoor of the test, described below) to a high of 145. Fif-
teen percent had IQ scores of 85 (1 SD below the mean) or
below. This percentage is approximately the expected propor-
tion of the population on the low end of the IQ distribution
(16% of the population is expected to be 1 SD below the mean
or lower). Reﬂecting Wisconsin’s population at the mid-20th
century, the WLS sample is racially and ethnically homoge-
neous; 99.2% are White (84.2% of northern or central European
heritage).
In 2006 and 2007, WLS collected saliva samples from partic-
ipants using Oragene kits (DNA Genotek, Inc.) and a mailback
protocol patterned closely on a previous Swedish study (see
Rylander-Rudqvist et al., 2006). Oragene kitswere selected because
of their ability to be used in a mailback protocol (e.g., no need for
immediate freezing) and their high averageDNAyield (in our sam-
ple,median= 319μg/mL,mean= 400μg/mL, SD= 284μg/mL).
All participants provided informed consent under a protocol
approved by the Institutional Review Board of the University
of Wisconsin-Madison. 56% of WLS participants alive in 2006
provided saliva samples (n = 7044). Those who sent saliva had
one-half year more schooling (13.9 years vs. 13.4 years, p< 0.001),
three points higher IQ scores (103.2 vs. 99.5,p< 0.001), andhigher
high school rank (54.6 vs. 46.7, p< 0.001) than those who did not
return saliva samples. Otherwise, they were representative of the
WLS sample as a whole.
Of the 7044 saliva samples, 15 were not used for the present
analysis because of ambiguous sex determination. Another 297
were not used because there was insufﬁcient DNA for the CGG
repeat assay. Therefore, the present study is based on 6732 cases
Frontiers in Genetics | Genetic Disorders September 2014 | Volume 5 | Article 309 | 2
Mailick et al. Low-normal FMR1 CGG repeat length
whose saliva sample yielded sufﬁcient DNA for the CGG repeat
assay, of whom 3263 (48.5%) were males and 3469 (51.5%) were
females. These cases included 1311 sibling pairs.
DETERMINATION OF THE FMR1 CGG TRIPLET REPEAT NUMBER
The number of FMR1CGG repeats was determined for all biologi-
cal samples using a PCR-based protocol that incorporated reagents
developed and manufactured by Celera Corporation. The speciﬁc
procedureswe usedwere described previously (Seltzer et al., 2012).
The protocol combined gene-speciﬁc primers that ﬂank the CGG
repeat region of the FMR1 gene with gender-speciﬁc primers, a
polymerase mixture, and a reaction buffer that is optimized for
ampliﬁcation of GC-rich DNA. Besides CGG repeat data, this
assay also detects the presence of X and Y chromosomes within
a sample, enabling sex conﬁrmation and identifying female sam-
ples with a single detectable CGG repeat (apparent homozygosity).
Data were analyzed using GeneMapper® v. 4.0 (Applied Biosys-
tems). CGG triplet repeats were calculated using the following
formula: number of CGG repeats = (peak size–193)/3.
CLASSIFICATION OF LOW-NORMAL CGG REPEATS
Wedeﬁned the upper boundary of low-normal CGG repeats based
on the distribution of CGG repeats in the WLS population. The
mean was 30.6 CGGs, with a standard deviation of 3.8. Two stan-
dard deviations below the mean was 23 CGG repeats or fewer. For
males, their FMR1 gene on the X chromosome had to have 23
or fewer CGG repeats to be classiﬁed into the low-normal group.
Otherwise, they were classiﬁed as having normal CGG repeats
(i.e., 24–40 CGG repeats). Males with 41 or more CGG repeats
were omitted from the present analysis (n = 164).
For females, both of their FMR1 alleles had to have 23 or fewer
CGG repeats to be included in the low-normal group. Females
with 24–40 CGG repeats on both alleles were classiﬁed as hav-
ing normal-length CGG repeats (n = 2452). Omitted from the
present analysis were females with any gray zone or premutation-
length CGG repeats (n = 295), as well as those who had one
low-normal and one normal CGG repeats (n = 676). For females,
we dropped those with one normal and one low-normal allele
because we did not have access to X-inactivation data, and thus it
was not possible to determine the proportion of normal alleles vs.
the proportion of low-normal alleles that were active for any given
sample member.
Based on these deﬁnitions, 341 males (11%) and 46 females
(1.8%) were classiﬁed as having low-normal CGG repeats and
2758 males and 2452 females were classiﬁed as having normal-
length CGG repeats. For males, the lowest number of CGG repeats
in this sample was 9, whereas for females, the lowest was 11 CGG
repeats.
MEASUREMENT OF DEMOGRAPHIC AND PHENOTYPIC
CHARACTERISTICS
Three rounds of data from the WLS were used to measure the
variables for the present study: demographic data collected in 1957
and 2011, identiﬁcation of number of children and children with
disabilities in the 2004/06 and 2011 rounds of data collection,
and outcome data collected in 2011, when respondents averaged
71 years of age.
For the present study we included three variables from the 1957
data: the years of education completed by respondent’s father and
mother, and the respondent’s IQ score as measured in high school.
Scores on the Henmon-Nelson Test of Mental Ability (Henmon
and Nelson, 1937), administered at age 17, were available for all
WLS respondents. As noted, IQ scores ranged from 61 to 145
(mean = 103.3, SD = 15.0). The test measures a wide variety of
mental abilities, including verbal, spatial, and numerical knowl-
edge and reasoning, the composite of which reﬂects generalized
intellectual functioning. Reliability coefﬁcients for the Henmon-
Nelson are consistently around 0.90 (Buros, 1940). The scores
on the original version of the test show good predictive validity
in forecasting academic success in college (Drake and Henmon,
1937), and scores on a later revision were correlated 0.83 with IQs
from an individually administered test of intelligence (Wagner,
1981). Within the WLS sample, Henmon-Nelson IQs were corre-
lated 0.60 with high school grade rank, which is consistent with
the usual associations found between IQ and school achievement
(Gregory, 2004).
Other demographic characteristics used to describe the sample
for the current study were years of education completed by the
respondent, household income of the respondent, and marital
status (1 = currently married, 0 = not currently married). These
demographic characteristics reﬂect status as of the 2011 round of
data collection.
We compared those with normal and low-normal CGG repeats
with respect to outcome variables in the following domains: cogni-
tion, mental health, cancer, and having children with disabilities.
Cognition was measured in 2011 by the HUI Mark 3 cognition
score (Feeny et al., 1996), which has six levels of cognitive func-
tioning based on respondents’ answers to two questions: “how
would you describe your ability to remember things?” and “ how
would you describe your ability to think and solve day to day prob-
lems?” The six levels of cognitive score are: 1 = able to remember
most things, think clearly and solve day to day problems; 2 = able
to remember most things, but have a little difﬁculty when trying to
think and solve day to day problems; 3 = somewhat forgetful, but
able to think clearly and solve day to day problems; 4 = somewhat
forgetful, and have a little difﬁculty when trying to think or solve
day to day problems; 5 = very forgetful, and have great difﬁculty
when trying to think or solve day to day problems; and 6 = unable
to remember anything at all, and unable to think or solve day to
day problems. The majority (60.8%) were in the least impaired
category of this measure, and less than 1% classiﬁed themselves in
the most impaired category.
Mental health was measured by anxiety, depression, and alco-
hol symptoms. Anxiety was measured by the Spielberger Anxiety
Index (Spielberger et al., 1970), which is a summary score of seven
items asking the number of days during the past week respondents
felt each emotional state: calm, tense, being at ease, worrying over
possible misfortune, nervous, jittery, and relaxed. For depression,
respondents reported whether since the previous WLS interview
(an average of 6 years previously), they experienced a period
of 2 weeks or more when nearly every day they felt sad, blue,
depressed, or when they lost interest in most activities, such as
work, hobbies, or things they usually liked to do for fun (1 = yes,
0 = no). Episodes of depression associated with physical illness,
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medications, and alcohol or drug use were not included in this
measure. For alcohol symptoms, respondents reported whether
they had to drink more to get the same effect as when they ﬁrst
started drinking (1 = yes, 0 = no). This is a standard item from the
DSMused to determinewhether an individual has developed a tol-
erance for alcohol and the effect refers to the feeling the individual
is trying to achieve by drinking (typically a feeling of intoxication).
Cancer (for women) included lifetime history of breast cancer
(coded 1 if yes and 0 if no) and uterine cancer (similarly coded).
For women, having children with disabilities was coded 1 if the
respondent had a biological child with a developmental disability
or mental health condition, and 0 if not. For men, the analy-
sis of this variable was restricted to fathers of daughters, as it is
only daughters who inherit a father’s X chromosome. Respon-
dents who had children with disabilities were identiﬁed through
a series of screener questions asked during the 2004/06 and 2011
rounds of data collection. The screener consisted of amaximumof
31 questions that began by asking parents if any of their children
(living or deceased) had an intellectual or developmental disabil-
ity and the speciﬁc diagnosis. If the parent indicated a speciﬁc
condition (e.g., Down syndrome, fragile X syndrome, autism),
or used terms such as developmental disability, mental retarda-
tion, or cognitive disability, he or she was coded as having a child
with a disability. In a small number of cases (5.4%), the par-
ent did not know the speciﬁc diagnosis given to his or her child,
but indicated that the child had difﬁculties in school. In such
cases, branching follow-up questions asked if the child was below-
average in intelligence, attended special education classes, and/or
had difﬁculty performing activities of daily living. If so, he or
she was classiﬁed as having a disability. Other childhood disabil-
ities mentioned by the respondents were noted, such as attention
deﬁcit hyperactivity disorder, seizure disorder, etc., and included
in this measure of having a child with a disability. Parents also
reported whether a child had been diagnosed by a health profes-
sional with schizophrenia, bipolar disorder, or a major clinical
depression (that required hospitalization or limited the ability of
the person to carry on activities of daily living). Suicide in a child
was based on parental report of cause of death. Other mental
health diagnoses mentioned by parents, such as anxiety disorders,
were noted and included in this measure of having a child with a
disability.
STATISTICAL ANALYSIS
For each outcome variable, we estimated a regression model,
including controls for age and sex, and the category of CGG repeat
(normal or low-normal). We controlled for age and sex because
of known associations between these variables and several of the
outcome variables (e.g., cognition, health) and because of the wide
age range of the sample (46 to 92 in 2011).We used the generalized
estimating equation (GEE; Diggle et al., 2013) approach to regres-
sion modeling, and report regression coefﬁcients (for continuous
outcome variables) or odds ratios (for binary outcome variables)
with robust standard errors and 95% conﬁdence intervals based
on clustering at the level of sibling pair. We also tested the Sex X
CGG repeat category interaction effect. We report coefﬁcients or
odds ratios for age and sex from the models without the interac-
tion. If the interaction was not signiﬁcant, we also report the CGG
repeat effect from this same model. If the interaction was signif-
icant, it is reported, and separate CGG effects are reported for
males and females. Use of the GEE modeling approach was moti-
vated by the study design, which as noted earlier, included 1311
sibling pairs whose endpoints on the outcome variables might be
correlated.
Due to variable amounts of missing data across outcome vari-
ables, sample sizes for males in the low-normal CGG repeat
category ranged from 304 to 341, and in the normal CGG repeat
category ranged from 2418 to 2690. For females, sample sizes in
the low-normal CGG repeat category ranged from 42 to 46, and
in the normal CGG repeat category from 2213 to 2404.
RESULTS
DEMOGRAPHIC CHARACTERISTICS
In the aggregate, participants in the present studywith low-normal
CGG repeat lengths did not differ signiﬁcantly from thosewhohad
normal length CGG repeats with respect to any of the background
demographic characteristics. As shown inTable 1, their fathers and
mothers had similar levels of education (between 9 and 11 years).
When inhigh school, the twogroups of participants had equivalent
standardized IQ score measurements (between 103 and 106). The
two groups had almost identical years of education (13–14 years).
They did not differ in their number of biological children (ranging
from 2.5 to 2.8).
At an average age of 71, those who had low-normal numbers
of CGG repeats did not differ from those with normal numbers
of CGG repeats in current marital status (with 83 to 84% of
males and 64 to 66% of females currently married) or household
income.
DIFFERENCES IN OUTCOME VARIABLES BETWEEN THOSE WITH
LOW-NORMAL CGGS vs. NORMAL CGG REPEATS
Table 1 also shows the means and standard deviations for the
outcome variables, broken down by low-normal and normal CGG
categories. Table 2 presents the results of the regression models
that tested whether and how those in the low-normal CGG repeat
category differed from those in the normal category with respect
to the outcome variables. All models adjusted for age. In models in
which the Sex X CGG repeat category interaction term was non-
signiﬁcant, the regression models also adjusted for sex. In models
with a signiﬁcant interaction term, differences in the outcome
variables were reported separately by sex.
Cognition
Sample members with low-normal numbers of CGGs had more
compromised cognitive functioning than those with normal num-
bers of CGG repeats, reﬂecting that those with low-normal
numbers of CGG repeats reported more difﬁculty “remembering
things and thinking and solving day to day problems” during the
past 4 weeks than those with normal numbers of CGGs (p< 0.05).
Note that although those with low numbers of CGGs reported
greater cognitive difﬁculties in later life, they did not differ in IQ
score as measured when they were in high school (see Table 1).
Mental health
There was no detected effect of CGG repeat category on anx-
iety or depression. There was a signiﬁcant Sex X CGG repeat
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Table 1 | Descriptive statistics by CGG repeat category and sex.
Males Females
Low-Normal1 Normal2 Low-Normal3 Normal4
Mean (s.d.) Mean (s.d.) Mean (s.d.) Mean (s.d.)
Demographic variables
Age in 2011 (years) 71.2 (4.0) 71.2 (4.1) 70.4 (4.2) 71.0 (4.1)
Years of education – Father 10.1 (3.4) 10.0 (3.5) 9.1 (3.5) 9.8 (3.5)
Years of education – Mother 10.8 (3.1) 10.7 (2.8) 10.9 (3.1) 10.6 (2.8)
Years of education – Respondent 14.4 (2.6) 14.3 (2.6) 13.6 (2.2) 13.6 (2.2)
IQ score 103.5 (16.1) 103.0 (15.4) 105.8 (14.6) 103.5 (14.7)
Number of biological children 2.53 (1.57) 2.57 (1.53) 2.67 (1.70) 2.76 (1.63)
Marital status (2011; 1 = married, 0 = other) 0.832 (0.374) 0.842 (0.364) 0.643 (0.484) 0.660 (0.473)
Household income in dollars (2011)5 43030 (46550) 40800 (44948) 29304 (34612) 28874 (28754)
Outcome variables
Cognition (1 = least problems to 6 = most problems) 2.03 (1.26) 1.86 (1.18) 1.83 (1.27) 1.80 (1.13)
Anxiety 6.24 (6.95) 6.22 (7.19) 9.93 (9.95) 7.54 (7.54)
Depressive episode in last 6 years (1 = yes, 0 = no) 0.032 0.049 0.192 0.102
Need to drink more for the same effect (1 = yes, 0 = no) 0.133 0.123 0.192 0.039
Breast cancer (1 = yes, 0 = no) n/a n/a 0.195 0.091
Uterine cancer (1 = yes, 0 = no) n/a n/a 0.049 0.013
Has biological child with disabilities (1 = yes, 0 = no)6 0.068 0.044 0.219 0.115
1Sample size ranges from 304 to 341; 2Sample size ranges from 2418 to 2690; 3Sample size ranges from 42 to 46; 4Sample size ranges from 2213 to 2404; 5Median
income is reported with interquartile range in parenthesis; 6Based on females who had at least one biological child and males who had at least one biological daughter.
category interaction (p < 0.01) with respect to the self-reported
perception of needing to drink more to have the same effect (see
Figure 1). Females in the low-normal CGG repeat category had
nearly six times the odds of needing to drink more to have the
same effect than females in the normal CGG repeat category (odds
ratio= 5.99, p< 0.001), whereas formales, there was no difference
between those in the low-normal vs. normal CGG repeat category.
Cancer
Women in the low-normal CGG repeat category had two and a
half times the odds of having had breast cancer than those in the
normal repeat category (odds ratio = 2.53, p < 0.05), and at a
trend level had almost four times the odds of having had uterine
cancer (odds ratio = 3.73, p = 0.074).
Having a child with disabilities
Respondents in the low-normal CGG repeat category had signif-
icantly greater odds of having had a child with a disability than
those in the normal CGG repeat category (odds ratio = 1.68,
p< 0.05). Table 3 lists the types of disabilities of the childrenwhose
parents had low-normal CGG repeats vs. those whose parents had
normal numbers of CGG repeats. Due to the small numbers of
each type of disability, we did not carry out statistical tests of differ-
ences in prevalence of speciﬁc categories between the low-normal
and normal CGG repeat group, but inspection of the data suggests
that the apparent excess in the low-normal CGG category reﬂected
higher numbers of children with ADHD/LD/seizures, intellectual
disability, bipolar disorder, and suicide.
DISCUSSION
In line with the hypothesis that there is a need for tight neu-
ronal homeostatic control mechanisms for optimal cognitive and
behavioral functioning (Ramocki and Zoghbi, 2008), we report
descriptive data to suggest that having numbers of CGG repeats
on the low end of the normal distribution may be associated
with poorer outcomes. Older men and women with CGG repeats
at least two standard deviations below the mean had signiﬁ-
cantly more difﬁculty with their memory and ability to solve day
to day problems. Women with both FMR1 alleles in the low-
normal category had signiﬁcantly elevated odds of feeling that
they need to drink more to get the same effect as in the past.
These women also had elevated odds of breast and uterine can-
cer. Men and women with low-normal CGGs had higher odds of
having a child with a disability, either a developmental disability
or a mental health condition. However, due to the small sample
size in the present study of individuals with low-normal CGGs
(particularly women), these ﬁndings need to be interpreted with
caution.
Thedifferences between groups thatwere foundacross domains
may be interrelated and thus may not be independent effects. For
example, a diagnosis of and treatment for breast or uterine can-
cer has been associated with cognitive difﬁculties (Burgess et al.,
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Table 2 | Generalized estimating equation analysis of CGG repeat category and outcome variables1.
Cognition Anxiety Recent
depressive
episode
(1 = yes, 0 = no)
Need to drink
more for the
same effect
(1 = yes, 0 = no)
Breast cancer
(1 = yes,
0 = no)
Uterine
cancer
(1 = yes,
0 = no)
Child with
disabilities2
(1 = yes,
0 = no)
b3 (s.e.)4 [95%
CI]
b (s.e.)
[95% CI]
Odds ratio
(s.e.) [95% CI]
Odds ratio (s.e.)
[95% CI]
Odds ratio
(s.e.) [95% CI]
Odds ratio
(s.e.) [95% CI]
Odds ratio
(s.e.) [95% CI]
Age (years) 0.02 (0.00)***
[0.01, 0.03]
−0.07 (0.03)*
[−0.13, −0.01]
0.98 (0.01)
[0.96, 1.01]
0.95 (0.01)***
[0.92, 0.97]
1.06 (0.02)**
[1.02, 1.09]
0.97 (0.04)
[0.91, 1.05]
0.98 (0.01)
[0.95, 1.00]
Sex (female = 1) −0.07 (0.03)*
[−0.14, −0.01]
1.39 (0.23)***
[0.93, 1.83]
1.71 (0.18)***
[1.39, 2.09]
0.31 (0.04)***
[0.23, 0.41]
– – 1.42 (0.17)**
[0.02, 0.76]
CGG repeat (low
repeat = 1)
0.15 (0.07)*
[0.01, 0.29]
0.35 (0.46)
[−0.55, 1.25]
0.91 (0.28)
[0.49, 1.67]
(For males) 1.08
(0.23) [0.71, 1.64]
(For females)
5.99 (3.13)***
[2.14, 16.7]
2.53 (1.02)*
[1.15, 5.61]
3.73 (2.75)+
[0.88, 15.82]
1.68 (0.34)*
[1.12, 2.50]
CGG repeat x
sex
– − − 5.53 (3.12)**
[1.82, 16.7]
− − −
p ≤ 0.10, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.
1Generalized estimating equation coefﬁcients (or odds ratio for binary dependent variables) with robust standard errors and 95% conﬁdence intervals are reported.
2The sample for the analysis was restricted to females who had at least one biological child or males who had at least one biological daughter (i.e., the outcome is a
probability of having a biological child with a non-normative condition, given that a respondent had at least one biological child, or one biological daughter in the case
of males).
3“b” refers to the regression coefﬁcient.
4“s.e.” refers to standard error.
FIGURE 1 | Estimated probability of needing to drink more for the
same effect, by CGG group and sex.
2005). Having a child with a disability has been shown to be asso-
ciated with elevated stress (Seltzer et al., 2011; Bailey et al., 2012),
which might lead to excess alcohol consumption. It is also pos-
sible that excess alcohol consumption may increase the risk of
cognitive difﬁculties. However, it also possible that some or all
of the outcomes were the direct effects of low numbers of CGGs
in the FMR1 gene, with downstream effects on cognition and
behavior. In the case of increased odds of cancer, past research
suggested that having low numbers of CGGs rescued embryos
carrying the BRCA1/2 mutation, an example of a direct biological
mechanism. The interrelatedness of the outcomes associated with
low-normal CGGs, as well as the mechanism by which these out-
comes emanate from lownumbers of CGGswarrants investigation
in future research.
Certain characteristics of the WLS make it a particularly useful
resource for exploring the effect of low-normal CGG repeats in
the FMR1 gene. It is a non-clinical study, and the sample members
were randomly selected from the population. Therefore, the results
were not based on clinic participants or study volunteers, nor
were they from members of families known to have abnormalities
in the FMR1 gene. Thus, the biases that may be introduced by
these factorswere avoided in the present sample. However, because
DNA was not obtained until 2006, attrition due to early death or
dropping out of the study limited the size of the sample for the
present analysis.
Another characteristic of the WLS was that nearly all study
participants were White, reﬂecting Wisconsin’s population in
the mid-20th century. Previous research (Gleicher et al., 2010)
reported that White females had higher rates of abnormal
CGG repeats (either higher or lower than the normal range)
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Table 3 | Conditions of children with disabilities.
Disability condition Normal CGGs1 Low-normal CGGs2
No disability 3884 (91.93%) 280 (91.20%)
ADHD, LD, seizures 68 (1.61%) 8 (2.61%)
Intellectual disability 22 (0.52%) 4 (1.30%)
Autism 7 (0.17%) 0
Genetic DD syndromes 3 (0.07%) 0
Cerebral palsy 12 (0.28%) 0
Down syndrome 7 (0.17%) 0
Brain injury 3 (0.07%) 0
Other DD 8 (0.19%) 0
Bipolar disorder 109 (2.58%) 10 (3.26%)
Depression 49 (1.16%) 2 (0.65%)
Schizophrenia 20 (0.47%) 0
Suicide 7 (0.17%) 2 (0.65%)
Other MI 26 (0.62%) 1 (0.33%)
1341 sample members [of 4225, or 8.1% of sample members with at least one
biological child (for females) or at least one biological daughter (for males)] with
normal numbers of CGG repeats had a child with a disability.
227 sample members [of 307, or 8.8% of sample members with at least one
biological child (for females) or at least one biological daughter (males)] with low-
normal numbers of CGG repeats had a child with a disability.
than females of African or Asian descent, and in the Gleicher
study, it was only in White females where both alleles were
abnormal.
Additionally, WLS collected the data for the outcome vari-
ables that we examined in this study when participants were
older adults (mean age = 71). It is known that FMR1 CGG
expansions result in an increasing phenotype as adults age. For
example, symptoms of fragile X-associated tremor/ataxia syn-
drome (FXTAS) become evident after the age of 50 in some men
and fewer women with premutation expansions (Hagerman and
Hagerman, 2004), and an age-associated pattern of worsening
linguistic dysﬂuency is also evident in women with premuta-
tion expansions (Sterling et al., 2013). It is similarly possible
that the effects of low numbers of CGG repeats may not mani-
fest until older age. The demographic data we reported on the
WLS participants, collected earlier in their lifespan, suggest a
similar age-associated pattern of low-CGG effects, as study par-
ticipants with low-normal CGGs did not have a lower IQ score
in high school or fewer years of education than those with nor-
mal numbers of CGG repeats, but in older age they did have
more difﬁculties with cognition. The lifetime risk of cancer is
best measured later in life, again revealing why the WLS is a
particularly unique and valuable resource for this preliminary
investigation.
However, the study has several limitations. In addition to the
small sample size, the present ﬁndings should not be general-
ized to non-white racial and ethnic groups, given the known
reduction in prevalence of both expansions and low numbers
of CGG repeats in the FMR1 gene. Furthermore, direct clinical
phenotyping of individuals with low numbers of CGG repeats
would be needed to conﬁrm the patterns in the secondary anal-
ysis of data reported here, as the data were collected for other
purposes. A related limitation is that the phenotypic data were
based on self-reports. Mechanistic investigations are needed to
identify direct effects of low CGGs and to differentiate them from
secondary effects. In addition, future research that tracks intergen-
erational transmission of low numbers of CGG repeats would be
extremely valuable. It is unfortunate that the WLS did not collect
DNA from the children of participants. Such data could have pro-
vided a deeper understanding of the elevated risk of child disability
in the next generation of study participants with low numbers of
CGG repeats, as well as the stability of transmission of low-normal
CGG repeats.
In conclusion, this preliminary investigation suggests that
low-normal numbers of CGG repeats may have substantial impli-
cations for cognitive functioning, cancer, and the odds of having
children with neurodevelopmental or neuropsychiatric condi-
tions. Larger epidemiological studies as well as biologically based
mechanistic investigations are necessary next steps.
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